PDL BioPharma (PDLI) Posts Q1 EPS of $0.04

May 3, 2017 4:56 PM UTC

PDL BioPharma (NASDAQ: PDLI) reported Q1 GAAP EPS of $0.04, which may not compare to the analyst estimate of $0.05. Revenue for the quarter came in at $45.4 million versus the consensus estimate of $50.23 million.

For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings